Rong
@rongl.bsky.social
Associate Editor at Nature Biotechnology. Views are my own.
Looking forward to #SITC25 next week! Please get in touch if you’d like to discuss your upcoming submissions to Nature Biotechnology! @natbiotech.nature.com
Join us as we take a step back in time and celebrate all we have accomplished in immuno-oncology over the past 40 years! We will be remembering all our IO milestones as we lead up to our 40th Anniversary Annual Meeting! sitcancer.org/2025/home
October 30, 2025 at 10:13 AM
Looking forward to #SITC25 next week! Please get in touch if you’d like to discuss your upcoming submissions to Nature Biotechnology! @natbiotech.nature.com
New online in @natbiotech.nature.com : The interactions of CAT-T cells and solid tumors are modeled on a chip.
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors - @pennengineering.bsky.social @pennmedicine.bsky.social go.nature.com/3Jc62gv
A tumor-on-a-chip for in vitro study of CAR-T cell immunotherapy in solid tumors - Nature Biotechnology
The interactions of CAR-T cells and solid tumors are modeled on a chip.
go.nature.com
October 28, 2025 at 9:02 AM
New online in @natbiotech.nature.com : The interactions of CAT-T cells and solid tumors are modeled on a chip.
The brief digital edition of our Nature Biotechnology October issue is live now! 🎉 Check it out here: mp.weixin.qq.com/s/nZSLSSxF4s... @natbiotech.nature.com
October 28, 2025 at 8:42 AM
The brief digital edition of our Nature Biotechnology October issue is live now! 🎉 Check it out here: mp.weixin.qq.com/s/nZSLSSxF4s... @natbiotech.nature.com
The brief digital edition of our @natbiotech.nature.com September issue is live now! Check it out here: mp.weixin.qq.com/s/vDXak-Ph4k...
September 28, 2025 at 6:19 AM
The brief digital edition of our @natbiotech.nature.com September issue is live now! Check it out here: mp.weixin.qq.com/s/vDXak-Ph4k...
Reposted by Rong
On our latest podcast, Barbara Cheifet talks with Zhenan Bao and John Rogers about the latest in electronic wearables and how they will complement and advance global health — from health monitoring in neonates to smart bandages for wounds shows.acast.com/forum/episod...
Wearables Roundtable: Bao and Rogers | Forum
shows.acast.com
September 17, 2025 at 2:29 PM
On our latest podcast, Barbara Cheifet talks with Zhenan Bao and John Rogers about the latest in electronic wearables and how they will complement and advance global health — from health monitoring in neonates to smart bandages for wounds shows.acast.com/forum/episod...
Reposted by Rong
Stereo-cell is a DNA nanoball array-based method that enables scalable, spatially resolved single-cell sequencing across diverse cell types and sizes with multimodal integration capabilities. #NBThighlight www.science.org/doi/10.1126/...
Stereo-cell: Spatial enhanced-resolution single-cell sequencing with high-density DNA nanoball-patterned arrays
Single-cell sequencing technologies have advanced our understanding of cellular heterogeneity and biological complexity. However, existing methods face limitations in throughput, capture uniformity, c...
www.science.org
August 22, 2025 at 11:39 AM
Stereo-cell is a DNA nanoball array-based method that enables scalable, spatially resolved single-cell sequencing across diverse cell types and sizes with multimodal integration capabilities. #NBThighlight www.science.org/doi/10.1126/...
The brief digital edition of our @natbiotech.nature.com August issue is live now! Check it out here: mp.weixin.qq.com/s/ZIDiPktIya...
August 14, 2025 at 9:50 AM
The brief digital edition of our @natbiotech.nature.com August issue is live now! Check it out here: mp.weixin.qq.com/s/ZIDiPktIya...
The brief digital edition of our June issue is live now! Check it out here: mp.weixin.qq.com/s/S9nAe_uF0Z...
June 22, 2025 at 6:35 AM
The brief digital edition of our June issue is live now! Check it out here: mp.weixin.qq.com/s/S9nAe_uF0Z...
Reposted by Rong
CD8-targeted lipid nanoparticles carrying anti-CD19 CAR mRNA were developed to generate CAR-T cells directly in vivo, demonstrating effective B cell depletion for potential treatment of B cell malignancies and autoimmune diseases. www.science.org/doi/10.1126/... #NBThighlight
In vivo CAR T cell generation to treat cancer and autoimmune disease
Chimeric antigen receptor (CAR) T cell therapies have transformed treatment of B cell malignancies. However, their broader application is limited by complex manufacturing processes and the necessity f...
www.science.org
June 20, 2025 at 7:01 AM
CD8-targeted lipid nanoparticles carrying anti-CD19 CAR mRNA were developed to generate CAR-T cells directly in vivo, demonstrating effective B cell depletion for potential treatment of B cell malignancies and autoimmune diseases. www.science.org/doi/10.1126/... #NBThighlight
The brief digital edition of our May issue is live now! Check it out here: mp.weixin.qq.com/s/Ph75nRcl02...
May 22, 2025 at 12:54 PM
The brief digital edition of our May issue is live now! Check it out here: mp.weixin.qq.com/s/Ph75nRcl02...
Reposted by Rong
A gene-editing treatment used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases #NBTNewsBeat www.nytimes.com/2025/05/15/h...
Baby Is Healed With World’s First Personalized Gene-Editing Treatment
www.nytimes.com
May 16, 2025 at 1:38 AM
A gene-editing treatment used on a 9½-month-old boy with a rare condition has the potential to help people with thousands of other uncommon genetic diseases #NBTNewsBeat www.nytimes.com/2025/05/15/h...
Reposted by Rong
This developer of cancer immunotherapies discusses her early fascination with cellular behavior, perseverance and deep desire to directly impact patient care go.nature.com/3RSlwqL
rdcu.be/ej8IO
rdcu.be/ej8IO
Five questions with Jie Sun - Nature Biotechnology
This developer of cancer immunotherapies discusses her early fascination with cellular behavior, perseverance and deep desire to directly impact patient care.
go.nature.com
May 1, 2025 at 2:25 PM
This developer of cancer immunotherapies discusses her early fascination with cellular behavior, perseverance and deep desire to directly impact patient care go.nature.com/3RSlwqL
rdcu.be/ej8IO
rdcu.be/ej8IO
Reposted by Rong
Cancer vaccines: the experts speak www.nature.com/articles/s41...
Cancer vaccines: the experts speak - Nature Biotechnology
The development of therapeutic cancer vaccines has long been a promising yet challenging field of research. While early efforts were impeded by limited efficacy and immune escape, recent advances in i...
www.nature.com
April 24, 2025 at 2:53 PM
Cancer vaccines: the experts speak www.nature.com/articles/s41...
Reposted by Rong
Synergizing advances in artificial intelligence with mathematical modeling will improve our ability to computationally predict immunotherapy outcomes go.nature.com/4jfqM3Y
rdcu.be/eh1qR
rdcu.be/eh1qR
April 24, 2025 at 9:48 PM
Synergizing advances in artificial intelligence with mathematical modeling will improve our ability to computationally predict immunotherapy outcomes go.nature.com/4jfqM3Y
rdcu.be/eh1qR
rdcu.be/eh1qR
Reposted by Rong
Cell therapies are transforming our ability to treat cancer but are out of reach for many patients. We asked experts to share their insights into the challenges and strategies to make these therapies more broadly accessible go.nature.com/3YCJn1o
rdcu.be/eiaZ4
rdcu.be/eiaZ4
Making cell therapy accessible: challenges and opportunities - Nature Biotechnology
Despite major advances in bringing cancer cell therapies to the clinic, their widespread accessibility remains a substantial challenge. High manufacturing costs, lack of funding and varying regulatory...
go.nature.com
April 25, 2025 at 12:12 AM
Cell therapies are transforming our ability to treat cancer but are out of reach for many patients. We asked experts to share their insights into the challenges and strategies to make these therapies more broadly accessible go.nature.com/3YCJn1o
rdcu.be/eiaZ4
rdcu.be/eiaZ4
Reposted by Rong
The identification of novel targets together with technological advances is transforming our ability to effectively modulate the tumor microenvironment go.nature.com/42Bo9lT
rdcu.be/eiiow
rdcu.be/eiiow
Turn cold tumors hot by reprogramming the tumor microenvironment - Nature Biotechnology
The identification of novel targets together with technological advances is transforming our ability to effectively modulate the tumor microenvironment.
go.nature.com
April 25, 2025 at 12:02 PM
The identification of novel targets together with technological advances is transforming our ability to effectively modulate the tumor microenvironment go.nature.com/42Bo9lT
rdcu.be/eiiow
rdcu.be/eiiow
The brief digital edition of our 2025 Cancer Immunotherapy Focus Issue is live as well! Check it out here: mp.weixin.qq.com/s/i5t1sfgpL-...
April 18, 2025 at 10:36 AM
The brief digital edition of our 2025 Cancer Immunotherapy Focus Issue is live as well! Check it out here: mp.weixin.qq.com/s/i5t1sfgpL-...
Reposted by Rong
Cell therapies are transforming our ability to treat cancer but are out of reach for many patients. @natbiotech.nature.com asked experts to share their insights into pressing challenges and promising strategies to make these therapies more broadly accessible www.nature.com/articles/s41...
Making cell therapy accessible: challenges and opportunities - Nature Biotechnology
Despite major advances in bringing cancer cell therapies to the clinic, their widespread accessibility remains a substantial challenge. High manufacturing costs, lack of funding and varying regulatory...
www.nature.com
April 16, 2025 at 9:59 AM
Cell therapies are transforming our ability to treat cancer but are out of reach for many patients. @natbiotech.nature.com asked experts to share their insights into pressing challenges and promising strategies to make these therapies more broadly accessible www.nature.com/articles/s41...
Reposted by Rong
Innate immune cells are promising candidates for cancer immunotherapy and various engineering strategies can be employed to set them up for success. Read about is in this Review in @natbiotech.nature.com and don't forget to check out our full Focus Issue! www.nature.com/articles/s41...
Engineering innate immune cells for cancer immunotherapy - Nature Biotechnology
The unique attributes of innate immune cells position them as attractive candidates for cancer immunotherapy, with engineering strategies to enhance their antitumor potential, offering notable therape...
www.nature.com
April 15, 2025 at 7:47 AM
Innate immune cells are promising candidates for cancer immunotherapy and various engineering strategies can be employed to set them up for success. Read about is in this Review in @natbiotech.nature.com and don't forget to check out our full Focus Issue! www.nature.com/articles/s41...
This month, we've focused on recent developments as well as challenges in cancer immunotherapy, including cancer vaccines, immune checkpoint inhibitors, and CAR-engineered cells. Please read more👇
Spotlight on cancer immunotherapies go.nature.com/3XUTPkM
April 15, 2025 at 6:48 AM
This month, we've focused on recent developments as well as challenges in cancer immunotherapy, including cancer vaccines, immune checkpoint inhibitors, and CAR-engineered cells. Please read more👇
Our 2025 Focus issue on Cancer Immunotherapy is live now! More details below
The April issue is live, with a focus on cancer immunotherapy nature.com/nbt/volumes/...
On the cover, recent clinical trials and patient reports have found promising outcomes of locoregional administration of CAR T cells across different solid tumors go.nature.com/3Z4eBiQ
On the cover, recent clinical trials and patient reports have found promising outcomes of locoregional administration of CAR T cells across different solid tumors go.nature.com/3Z4eBiQ
April 15, 2025 at 6:47 AM
Our 2025 Focus issue on Cancer Immunotherapy is live now! More details below
Reposted by Rong
⭐ I'm hiring a new Chief editor for Nature Biomedical engineering, in New York, Beijing or Shanghai.
Please apply here: springernature.wd3.myworkdayjobs.com/SpringerNatu...
Please apply here: springernature.wd3.myworkdayjobs.com/SpringerNatu...
April 4, 2025 at 10:07 AM
⭐ I'm hiring a new Chief editor for Nature Biomedical engineering, in New York, Beijing or Shanghai.
Please apply here: springernature.wd3.myworkdayjobs.com/SpringerNatu...
Please apply here: springernature.wd3.myworkdayjobs.com/SpringerNatu...
Reposted by Rong
Sonogenetic EchoBack-CAR T cells incorporate an ultrasensitive heat-shock promoter and synthetic positive feedback loop, enabling focused-ultrasound-controlled long-lasting CAR expression and enhanced anti-tumor efficacy. www.cell.com/cell/fulltex... #NBThighlight
Engineering sonogenetic EchoBack-CAR T cells
Sonogenetic EchoBack-CAR T cells were designed with an ultrasensitive heat-shock promoter
screened from a library and a synthetic positive feedback loop that reprograms tumor
engagement into CAR T cel...
www.cell.com
April 4, 2025 at 8:33 AM
Sonogenetic EchoBack-CAR T cells incorporate an ultrasensitive heat-shock promoter and synthetic positive feedback loop, enabling focused-ultrasound-controlled long-lasting CAR expression and enhanced anti-tumor efficacy. www.cell.com/cell/fulltex... #NBThighlight
Reposted by Rong
Writing is the most essential activity of a scientist because without writing there is no thinking and no real opportunity for exchange in the marketplace of ideas go.nature.com/4iXlwRQ
rdcu.be/ee4X5
rdcu.be/ee4X5
An open letter to graduate students and other procrastinators: it’s time to write - Nature Biotechnology
Nature Biotechnology - An open letter to graduate students and other procrastinators: it’s time to write
go.nature.com
April 2, 2025 at 9:10 PM
Writing is the most essential activity of a scientist because without writing there is no thinking and no real opportunity for exchange in the marketplace of ideas go.nature.com/4iXlwRQ
rdcu.be/ee4X5
rdcu.be/ee4X5
Reposted by Rong
2H24 biotech job picture go.nature.com/42hUCgY
2H24 biotech job picture - Nature Biotechnology
A semiannual snapshot of job expansions, reductions and availability in the biotech and pharma sectors.
go.nature.com
April 1, 2025 at 10:12 PM
2H24 biotech job picture go.nature.com/42hUCgY